ELMD (Electromed) Cyclically Adjusted Revenue per Share: $5.58 (As of Mar. 2026)


ELMD Electromed Inc ELMD
85 GF Score
Price $45.65
GF Value $25.31
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Electromed Cyclically Adjusted Revenue per Share?

Electromed ELMD -0.37% 85 Cyclically Adjusted Revenue per Share is $5.58 as of Mar. 2026. GuruFocus rates ELMD with a GF Score™ of 85/100 and a GF Value™ of $25.31 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Electromed's adjusted revenue per share for the three months ended in Mar. 2026 was $2.148. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $5.58 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Electromed's average Cyclically Adjusted Revenue Growth Rate was 12.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Electromed was 12.70% per year. The lowest was 9.30% per year. And the median was 11.75% per year.

As of today (2026-07-12), Electromed's current stock price is $45.65. Electromed's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $5.58. Electromed's Cyclically Adjusted PS Ratio of today is 8.18.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Electromed was 8.18. The lowest was 1.75. And the median was 3.46.


Electromed  (AMEX:ELMD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Electromed's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=45.65/5.58
=8.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Electromed was 8.18. The lowest was 1.75. And the median was 3.46.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Electromed Cyclically Adjusted Revenue per Share Related Terms


Electromed Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Electromed's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromed Cyclically Adjusted Revenue per Share Chart

Electromed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.21 3.68 4.10 4.59 5.12

Electromed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.96 5.12 5.27 5.37 5.58

ELMD vs CATX, MASS, CV: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Electromed's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromed Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromed's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Electromed's Cyclically Adjusted PS Ratio falls into.


ELMD
85GF Score
Electromed Inc ELMD
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Electromed Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Electromed's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.148/330.2130*330.2130
=2.148

Current CPI (Mar. 2026) = 330.2130.

Electromed Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.682 241.018 0.934
201609 0.656 241.428 0.897
201612 0.756 241.432 1.034
201703 0.789 243.801 1.069
201706 0.856 244.955 1.154
201709 0.732 246.819 0.979
201712 0.805 246.524 1.078
201803 0.832 249.554 1.101
201806 0.918 251.989 1.203
201809 0.842 252.439 1.101
201812 0.924 251.233 1.214
201903 0.860 254.202 1.117
201906 0.999 256.143 1.288
201909 0.960 256.759 1.235
201912 0.976 256.974 1.254
202003 0.985 258.115 1.260
202006 0.762 257.797 0.976
202009 0.893 260.280 1.133
202012 1.064 260.474 1.349
202103 0.987 264.877 1.230
202106 1.066 271.696 1.296
202109 1.126 274.310 1.355
202112 1.170 278.802 1.386
202203 1.160 287.504 1.332
202206 1.283 296.311 1.430
202209 1.227 296.808 1.365
202212 1.351 296.797 1.503
202303 1.386 301.836 1.516
202306 1.561 305.109 1.689
202309 1.403 307.789 1.505
202312 1.556 306.746 1.675
202403 1.560 312.332 1.649
202406 1.650 314.175 1.734
202409 1.633 315.301 1.710
202412 1.816 315.605 1.900
202503 1.749 319.799 1.806
202506 1.995 322.561 2.042
202509 1.945 324.800 1.977
202512 2.175 324.054 2.216
202603 2.148 330.213 2.148

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $5.58 mean?
Electromed (ELMD) has a Cyclically Adjusted Revenue per Share of $5.58 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Electromed and its competitors.
Is Electromed's Cyclically Adjusted Revenue per Share too high?
Electromed's current Cyclically Adjusted Revenue per Share is $5.58. Overall, Electromed has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's Cyclically Adjusted Revenue per Share compare to CATX and MASS?
Electromed's Cyclically Adjusted Revenue per Share of $5.58 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Electromed and its competitors. Electromed's current Cyclically Adjusted Revenue per Share is $5.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.31, compared to a current price of $45.65 — trading 80.4% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $5.58. Electromed's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Electromed (ELMD), the current Cyclically Adjusted Revenue per Share is $5.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Electromed (ELMD) Overvalued in 2026?

Based on GuruFocus' analysis, Electromed stock appears to be overvalued. The current stock price of $45.65 is trading 80.4% above its estimated GF Value™ of $25.31. GuruFocus considers Electromed to be Significantly Overvalued.

Key valuation signals for ELMD:

  • Cyclically Adjusted Revenue per Share: $5.58
  • GF Value™: $25.31 vs. price of $45.65 (80.4% above fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Electromed Business Description

Address 500 Sixth Avenue NW, New Prague, MN, USA, 56071
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
85GF Score

Get the complete analysis for ELMD

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.65
Price
$25.31
GF Value